Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00047281
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : July 11, 2017
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Schering-Plough
Celgene
Information provided by (Responsible Party):
Patrick Y. Wen, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2005
  Actual Study Completion Date : February 2006